Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content. If you have any issues relating to the topics here, please call the MS-UK Helpline on 0800 7830 518.


 

A large international study led by the University of Tasmania’s Menzies Institute for Medical Research has found that the age at which...

Changes in the composition of certain immune system cells may be associated with relapses in multiple sclerosis patients being treated with Gilenya (fingolimod), according to a study published in...

Posture control is a complex skill, requiring different areas of the nervous system to work well and to work together — but the damage caused by multiple sclerosis complicates such nervous system...

Anodal transcranial direct current stimulation (tDCS) over the right parietal cortex can help improve reaction times in visual vigilance tests but not subjective feelings of...

A study found that the cells responsible for the production of myelin selectively introduce a myelin-insulating layer in a particular set of neuronal axons in the brain’s white matter.

This...

Thousands of new immune system signals have been uncovered with potential implications for immunotherapy, autoimmune diseases and vaccine development.

The researchers behind the finding say...

New functional magnetic resonance imaging (MRI) studies appear to show higher lesion counts and greater lesion volumes exist in primary progressive multiple sclerosis (PPMS) patients who are...

In a large-scale, genome-wide analysis of more than 110,000 samples, a worldwide consortium of scientists has identified 200 genetic loci associated with MS. Their findings were presented in a...

According to a recent update on the Univadis website, patient-reported quality-of-life variables showed a preference for dimethyl fumarate compared to Fingolimod. Head-to-head trials comparing of...

Individuals with relapsing-remitting multiple sclerosis (RRMS) and an inadequate response to prior disease modifying therapies had a greater level of confirmed disability improvement (CDI) and a...

Pages